Peritonitis causes significant morbidity in chronic periinvolved in governing changes in peritoneal permeability to toneal dialysis patients [1, 2] . During the acute phase of small solutes and protein remain incompletely defined.
peritonitis, there is rapid migration of leukocytes into the Methods. We determined the importance of prostanoid production in the enhanced protein loss observed during acute peritoneal cavity and an increase in the permeability of peritonitis by inhibition experiments using indomethacin, an the peritoneum or peritoneal membrane to both protein 
fined.
All experiments were performed in male New Zealand White Local production of inflammatory mediators within the rabbits (2.6 to 3.4 kg body weight) using an eight-hour dwell peritoneum [6] , some of which can direct leukocyte migraof dialysate containing 2.5% glucose. Peritoneal permeability to creatinine and protein was assessed by time-dependent tion into the peritoneal cavity [7] , has been associated with changes in the dialysate to plasma concentration ratios of these changes in peritoneal permeability during peritonitis. For solutes.
example, Steinhauer and Schollmeyer showed that periResults. Series 1 experiments showed enhanced leukocyte toneal dialysate concentrations of prostaglandin E 2 (PGE 2 ), migration into the peritoneal cavity and increased peritoneal 6-keto-PGF 1␣ , PGF 2␣ and thromboxane B 2 increased durpermeability to protein during bacterial challenge that was ing episodes of peritonitis in continuous ambulatory periaccompanied by an increase in the dialysate concentrations of prostaglandin E 2 (PGE 2 ), 6-keto-PGF 1␣ , and interleukin-8, but toneal dialysis (CAPD) patients and that dialysate con- who showed that increased transperitoneal transport of Conclusions. Enhanced production of prostanoids likely protein and small solutes correlated with enhanced applays an important role in governing the increase in peritoneal pearance rates of tumor necrosis factor-␣ (TNF-␣), interleukin-6 (IL-6), and prostaglandins in peritoneal dialysate [9] . In that study, increases in transperitoneal
concentrations. An association between the appearance of certain prostaglandins and complement proteins in the peritoneal cavity and enhanced protein loss rates has respectively. The peritoneal cavity was then penetrated, and a peritoneal catheter (Sil-Med Corporation, Tauton, also been demonstrated in the rabbit during zymosaninduced peritonitis [10] . Other more recent studies have MA, USA) was inserted and secured with a purse-string suture. No additional anesthesia was given after surgery proposed that local production of nitric oxide can mediate changes in transperitoneal transport of both protein was completed. After surgical preparation, a baseline arterial blood and small solutes during peritonitis in the rat [11] [12] [13] . Despite these previously reported statistical correlations, sample was obtained. A washout exchange of the peritoneal cavity was then performed using 100 mL of Normothe relative importance of prostanglandins, cytokines, and nitric oxide in altering peritoneal permeability dursol R (Abbott Laboratories, North Chicago, IL, USA) for 15 minutes. Normosol R solutions had a pH of 6.8 ing peritonitis remains unclear.
We have developed a rabbit model of acute peritonitis and contained 140 mEq/L sodium, 5 mEq/L potassium, 98 mEq/L chloride, 27 mEq/L acetate, 3 mEq/L magnethat elicits both enhanced leukocyte migration into the peritoneal cavity and increased peritoneal permeability sium, and 23 mEq/L gluconate. A priming dose of 100 mg of creatinine (Sigma Chemical, St. Louis, MO, USA) to protein during the first eight hours of infection (abstract; Liu et al, J Am Soc Nephrol 5:462, 1994). In the dissolved in 20 mL of Normosol R was infused intravenously during a 10-minute interval. This was followed by present study, we describe the local release of certain inflammatory mediators into the peritoneal cavity in this a constant infusion of a Normosol R solution containing 1.65 mg/mL creatinine at a rate of 1.15 mL/min to mainmodel and determine the importance of prostanoid production in controlling protein permeability during peritotain a plasma creatinine concentration of approximately 10 mg/dL. After drainage of the washout exchange by nitis by inhibition experiments using indomethacin, an inhibitor of cyclooxygenase (COX) activity.
gravity, 120 mL of the dialysis solution (Dianeal PD-2) were instilled into the peritoneal cavity containing E. coli and indomethacin as required by the experimental METHODS design. All solutions were warmed to 37ЊC before infuExperimental design sion into the rabbit. Three milliliters of blood and 4 mL of dialysate were Two separate series of peritoneal dialysis experiments were performed in male New Zealand White rabbits obtained at 0, 2, 4, 6, and 8 hours after complete infusion of the dialysate into the peritoneal cavity. One hundred weighing between 2.6 and 3.4 kg. Series 1 experiments compared transperitoneal solute transport rates and dialmicroliters were taken from each of these dialysate samples to determine total and differential leukocyte counts, ysate concentrations of inflammatory mediators after the addition of 1 ϫ 10 6 colony forming units (cfu) of Escheand the remainder was centrifuged to ensure complete removal of particles and cells. The supernatant was colrichia coli (E. coli; catalog number 25922, N ϭ 7; American Type Culture Collection, Rockville, MD, USA) to the lected immediately into tubes containing sodium ethylenediaminetetraacetic acid, pH 7.2, and indomethacin peritoneal cavity with those from control rabbits without bacteria added to the dialysate (N ϭ 7). Series 2 experi-(10 mmol/L and 5.6 mol/L final concentrations, respectively) and was stored at Ϫ70ЊC until assays were perments compared transperitoneal solute transport rates and dialysate concentrations of inflammatory mediators formed. Additional 1 mL dialysate samples were obtained at 0.5, 1, and 3 hours after complete infusion of the with (N ϭ 4) and without (N ϭ 4) intraperitoneal administration of indomethacin (Merck, West Point, PA, USA) dialysate for determination of small solute and protein concentrations only. After taking the last samples, the at a concentration of 75 g/mL to dialysate containing 5 ϫ 10 5 cfu of E. coli. In all experiments, rabbits underperitoneal cavity was drained by gravity for five minutes, and the drained volume was measured to the nearest went an eight-hour exchange using 120 mL of dialysate containing 2.5% glucose (Dianeal PD-2; Baxter Healthmilliliter using a graduated cylinder. The experiment was then terminated by a barbiturate overdose. care, Deerfield, IL, USA).
Surgical procedure and experimental protocol
Analytical techniques Leukocytes in dialysate were counted using a hemocyThe surgical procedure and protocol for evaluating peritoneal permeability in these experiments were simitometer. The percentage of neutrophils in the dialysate was determined by using Wright's stain (Sigma Chemilar to those previously published [14, 15] . Rabbits fasted overnight and were anesthetized by an intramuscular cal). Plasma and dialysate concentrations of creatinine, glucose, and protein were measured using an automated injection of acepromazine maleate (16 mg/kg) and xylazine hydrochloride (3 mg/kg), followed 10 minutes later analyzer (Beckman CX3, Fullerton, CA, USA). Creatinine concentrations were corrected for high glucose conby an intramuscular injection of ketamine hydrochloride (50 mg/kg). A carotid artery and jugular vein were cannucentrations as described previously [15] . Prostaglandin E 2 and 6-keto-PGF 1␣ concentrations in lated for blood sampling and the infusion of solutions, the dialysate were determined by using commercially available immunoassays according to the instructions of Statistics the manufacturer (R&D Systems, Minneapolis, MN, All results were expressed as mean Ϯ SEM. The sig-USA). The minimum detection limit for both prostannificance of differences in the measured parameters as oids was 36.2 pg/mL. IL-8 was measured in peritoneal a function of dwell time between groups was first asdialysate by using an enzyme-linked immunosorbent sessed by analysis of variance (ANOVA) with repeated assay (Endogen, Cambridge, MA, USA) with a minimeasures. If this test indicated significant differences mum detection limit of 2 pg/mL. To assess local producbetween groups, the significance of differences at each tion of nitric oxide, the sum total of both nitrate and sampling time was assessed using a Student t test for nitrite (hereafter referred to as nitrate ϩ nitrite) concenunpaired data. P values less than 0.05 were considered trations was determined using a colorimetric assay (Caysignificant. man Chemical, Ann Arbor, MI, USA) with a minimum detection limit of 2.5 mol/L. The latter assay required two steps. The first is the conversion of all nitrate to RESULTS nitrite using nitrate reductase, and the second is the evaluation of nitrite concentration using the Griess reagents.
The effect of adding E. coli to peritoneal dialysate on the time dependence of dialysate leukocyte counts and Calculations the D/P protein concentration ratios is shown in Figures  1 and 2 , respectively. The addition of E. coli to the Peritoneal permeability to creatinine and total protein was evaluated by calculating the dialysate to plasma peritoneal cavity resulted in a substantial increase in dialysate leukocyte counts after four hours and a signifi-(D/P) concentration ratio at each sampling time. When the concentration in plasma was not measured at a given cant increase in the D/P protein concentration ratio at one, two, and eight hours of the dwell. The increase in dialysate sampling time, the value was interpolated from the bracketing concentrations. Creatinine and protein dialysate leukocyte counts was primarily due to neutrophils; the percentage of leukocytes in the dialysate that clearances averaged over the eight-hour dwell were calculated by multiplying D/P for creatinine and total prowere neutrophils at eight hours after the addition of E. coli to the peritoneal cavity was 92 Ϯ 3% (P Ͻ 0.01, tein, respectively, by the drained volume and dividing by the dwell time. Peritoneal permeability to glucose different from the 51 Ϯ 10% in control rabbits). Drained volume and creatinine clearance were marginally higher was evaluated by calculating the ratio of the dialysate concentration at each sampling time to the dialysate con-(P ϭ 0.078 and P ϭ 0.088, respectively) after intraperitoneal addition of E. coli than in control rabbits, and procentration immediately after complete infusion of the dialysis solution into the peritoneal cavity (D/D 0 ). tein clearance was significantly higher after intraperito- Figure 3 and Table 1 . Figure 3 shows the time dependence of 6-keto-PGF 1␣ (Fig. 3A) and PGE 2 (Fig. 3B ) concentrations in the dialysate during series 1 experi- with dwell time in series 1 experiments, and intraperitoneal addition of E. coli did not result in higher dialysate nitrate ϩ nitrite concentrations than those determined findings show that intraperitoneal administration of inin control rabbits (Table 1) . Dialysate concentrations domethacin resulted in peritoneal permeability to proof IL-8 were not consistently detectable in peritoneal tein similar to that observed in control rabbits not exdialysate until eight hours of the dwell. Intraperitoneal posed to bacteria in the dialysate (compare with the addition of E. coli resulted in a substantial increase in results from series 1 experiments). dialysate IL-8 concentrations after eight hours (Table 1) .
As expected, intraperitoneal administration of indoFigures 4 and 5 show the time dependence of dialysate methacin blocked prostanoid production during acute leukocyte counts and D/P protein concentration ratios peritonitis, as reflected by 6-keto-PGF 1␣ and PGE 2 conin series 2 experiments in which E. coli was added to centrations in the dialysate (Fig. 6 and Table 2 ) that the dialysate for both groups of rabbits. There was no were similar to those in control rabbits not exposed to effect of intraperitoneal administration of indomethacin bacteria in the dialysate. In contrast, dialysate concentraon the increase in dialysate leukocyte counts with dwell tions of nitrate ϩ nitrite and IL-8 were not influenced time (Fig. 4) , and the percentage of leukocytes in the by intraperitoneal administration of indomethacin. dialysate that were neutrophils was 95 Ϯ 1% with or Figure 7 shows the time dependence of D/P concentrawithout intraperitoneal administration of indomethacin. tion ratios for creatinine during both series 1 and 2 experIn contrast, intraperitoneal administration of indomethaiments. There was no effect of any study intervention on cin resulted in lower D/P protein concentration ratios either D/P creatinine or D/D 0 glucose (data not shown). (Fig. 5) , lower creatinine and protein clearances (Table 2) , and lower drained volumes of dialysate (Table 2) . These These findings demonstrate that the addition of bacteria N ϭ 4) . There was no effect of intraperitoneal administration SEM, and *P Ͻ 0.05 and **P Ͻ 0.01 denote significant decreases of indomethacin on dialysate leukocyte counts. Error bars denote Ϯ in D/P values at the indicated sampling times after intraperitoneal SEM.
administration of indomethacin compared with control values, respectively.
to the peritoneal cavity of the rabbit does not substan- relatively low for inflammatory sites, largely because of the large volume of dialysate present within the peritoneal cavity. Although E. coli is not the most common pathogen causing peritonitis in CAPD patients [1], the is not a feature of E. coli-induced peritonitis in the rabbit, magnitude of the increase in dialysate concentrations unlike that observed during peritonitis induced by lipoof 6-keto-PGF 1␣ , PGE 2 , and IL-8 is comparable to that polysaccharide or zymosan in the rat [11, 12] . observed during infection of the peritoneal cavity with Prostanoids (mainly PGI 2 and PGE 2 ) are generated other organisms in CAPD patients [8, 9, 16, 17] . While by the oxidation of arachidonic acid by COX and are increased dialysate concentrations of nitrate ϩ nitrite multifunctional mediators of inflammation. The vasohave been reported in one study of peritonitis in CAPD active properties of prostaglandins have been recognized patients [18] , an enhanced local production of nitric oxfor many years [20, 21] , and they exert their vasodilating ide was not observed by others [19] . The observations activities by binding to specific cell surface receptors. from the current study suggest that E. coli-induced periThis leads to activation of adenylate cyclase and subsetonitis in the rabbit elicits some of the same inflammatory quently to elevated intracellular cyclic adenosine monomediators as during peritonitis in CAPD patients. Furphosphate levels, which may in turn activate specific protein kinases. Prostaglandins, by themselves, do not alter thermore, these data show that production of nitric oxide tein [8] [9] [10] . Despite these statistical correlations, attempts to prove a causal relationship between prostanoid production and increased peritoneal permeability have not been convincing. Steinhauer and Schollmeyer observed lower rates of protein loss and lower dialysate concentrations of PGE 2 and 6-keto-PGF 1␣ after intraperitoneal administration of indomethacin in four CAPD patients who were initially resistant to antibiotic treatment [8]; however, the results from these four patients methacin in 11 episodes of peritonitis in nine CAPD patients than in an untreated (by indomethacin) historical control group [27] . Comparison between the experimental and control groups might not have been valid in vascular permeability to macromolecules; rather, they this study because the infections in the experimental can act synergistically with other inflammatory mediators group were more severe than in the control group, as to enhance vascular permeability [22, 23] . Indomethacin reflected by substantially higher dialysate leukocyte counts blocks the conversion of arachidonic acid to biologically (6267 ϫ 10 6 /L vs. 860 ϫ 10 6 /L, respectively). active prostanoids by inhibiting the activity of both iso-
The current study demonstrates that intraperitoneal forms of COX. It should be noted that the immunomodu-(IP) administration of indomethacin decreased the conlatory properties of indomethacin are not entirely the centrations of 6-keto-PGF 1␣ and PGE 2 in the dialysate result of its inhibition of the COX system and prostanoid and decreased peritoneal permeability to protein. These production [24] ; thus, the findings of the current study observations strongly suggest that enhanced prostanoid may be due to other actions of indomethacin, such as production is directly involved in increasing peritoneal alteration of second-messenger pathways [25] and cytopermeability to protein during acute peritonitis. Our rekine production [26] .
sults contrast with those previously reported by Forrest, Previous work in CAPD patients and in animal models Jose, and Williams, who evaluated the effect of prostanhas shown that peritoneal inflammation is accompanied oid generation on peritoneal permeability to protein durby an enhanced appearance of prostanoids in the peritoing zymosan-induced peritonitis in the rabbit [10] . These investigators observed a nonsignificant increase in dialyneal cavity and increased peritoneal permeability to pro-
